Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 14/20 | 1.00 |
| ▸ | FAAH | O00519 | 5/20 | 0.65 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.55 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.54 |
| ▸ | PKM | P14618 | 2/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.54 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 2/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | CCR6 | P51684 | 1/20 | 0.48 |
| ▸ | ATM | Q13315 | 1/20 | 0.48 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.48 |
| ▸ | BCHE | P06276 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22862058 | 0.94 | MGLL (0.89) | MGLLFAAHL3MBTL1HSP90AA1PKM | |
| SCHEMBL9156707 | 0.89 | MGLL (0.79) | MGLLFAAHL3MBTL1HSP90AA1PKM | |
| SCHEMBL2363989 | 0.87 | MGLL (0.77) | MGLLFAAHHSP90AA1PKMMAPK1 | |
| SCHEMBL23599861 | 0.83 | MGLL (0.71) | MGLLFAAHHSP90AA1PKMMAPK1 | |
| SCHEMBL27558830 | 0.83 | MGLL (0.71) | MGLLFAAHHSP90AA1PKMMAPK1 | |
| SCHEMBL19156143 | 0.83 | MGLL (0.71) | MGLLFAAHHSP90AA1PKMMAPK1 | |
| SCHEMBL1255913 | 0.82 | MGLL (0.71) | MGLLFAAHHSP90AA1PKMMAPK1 | |
| SCHEMBL22862128 | 0.82 | MGLL (0.71) | MGLLFAAHHSP90AA1PKMMAPK1 | |
| SCHEMBL8564255 | 0.82 | MGLL (0.71) | MGLLFAAHHSP90AA1PKMMAPK1 | |
| SCHEMBL95324 | 0.81 | MGLL (1.00) | MGLLFAAHHSP90AA1PKMMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110724154-A | Polysubstituted pyrrolo [3,4-d ] isoxazole derivative and synthetic method thereof | 湖北科技学院 | 2020-01-24 | — | — | CN | claimed |
| US-20250092171-A1 | HIGH-PURITY 4-(2-BROMOETHYL)BENZENESULFONIC ACID, HIGH-PURITY STYRENESULFONIC ACID COMPOUND DERIVED THEREFROM, AND POLYMER THEREOF, AND METHODS FOR PRODUCING SAME | TOSOH FINECHEM CORPORATION (JP) | 2025-03-20 | — | — | US | disclosed |
| EP-3666753-B1 | HIGH-PURITY AMPHIPATHIC ARYLSULFONIC ACID AMINE SALT VINYL MONOMER AND COPOLYMER THEREOF | TOSOH FINECHEM CORP (JP) | 2024-09-11 | — | — | EP | disclosed |
| US-20240191087-A1 | WATER DISPERSIBLE SULFONATED THERMOPLASTIC COPOLYMER FOR USE IN ADDITIVE MANUFACTURING | STRATASYS INC (US) | 2024-06-13 | — | — | US | disclosed |
| US-11939480-B2 | Water dispersible sulfonated thermoplastic copolymer for use in additive manufacturing | STRATASYS, INC. (US) | 2024-03-26 | — | — | US | disclosed |
| US-20230330245-A1 | ANTIBODY-EXATECAN CONJUGATES | SYNAFFIX B.V. (NL) | 2023-10-19 | — | — | US | disclosed |
| WO-2023192961-A2 | LIGAND-PAYLOAD CONJUGATES | PYXIS ONCOLOGY, INC. (US) | 2023-10-05 | — | — | WO | disclosed |
| WO-2023171597-A1 | HIGH-PURITY 4-(2-BROMOETHYL)BENZENESULFONIC ACID, HIGH-PURITY STYRENESULFONIC ACIDS DERIVED THEREFROM AND POLYMERS THEREOF, AND METHODS FOR PRODUCING SAME | 東ソー・ファインケム株式会社 | 2023-09-14 | — | — | WO | disclosed |
| US-11459410-B2 | High-purity amphipathic arylsulfonic acid amine salt vinyl monomer and copolymer thereof | TOSOH FINECHEM CORPORATION (JP) | 2022-10-04 | — | — | US | disclosed |
| CN-110997631-B | High purity amphiphilic arylsulfonic acid amine salt vinyl monomers and (co) polymers thereof | 东曹精细化工株式会社 | 2022-07-15 | — | — | CN | disclosed |
| US-20050009982-A1 | Compound having silsesquioxane skeleton and its polymer | CHISSO CORPORATION (JP) | 2005-01-13 | — | — | US | disclosed |
| EP-0722959-B1 | Highly oxygen-permeable heat-resistant material | MENICON CO LTD (JP) | 1998-04-08 | — | — | EP | disclosed |
| US-5587445-A | Highly oxygen-permeable heat-resistant material | MENICON CO., LTD. (JP) | 1996-12-24 | — | — | US | disclosed |
| EP-0722959-A2 | Highly oxygen-permeable heat-resistant material | Menicon Co., Ltd. (JP) | 1996-07-24 | — | — | EP | disclosed |
| EP-0393713-B1 | Process for the preparation of N-substituted maleimides | TOSOH CORP (JP) | 1994-06-29 | — | — | EP | disclosed |
| EP-0376336-B1 | N-substituted maleimide polymer composition | NIPPON OILS & FATS CO LTD (JP) | 1994-02-16 | — | — | EP | disclosed |
| US-5179162-A | Polyoxymethylene glycol blend with a maleimide polymer | NIPPON OIL & FATS CO., LTD. (JP) | 1993-01-12 | — | — | US | disclosed |
| US-5087705-A | Heating N-substituted maleamic acid monoester in presence of acid catalyst | SHIN-DAIKYOWA PETROCHEMICAL CO., LTD. (JP) | 1992-02-11 | — | — | US | disclosed |
| EP-0393713-A1 | Process for the preparation of N-substituted maleimides | Tosoh Corporation (JP) | 1990-10-24 | — | — | EP | disclosed |
| EP-0376336-A2 | N-substituted maleimide polymer composition | NIPPON OIL AND FATS COMPANY, LIMITED (JP) | 1990-07-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11459410-B2 | High-purity amphipathic arylsulfonic acid amine salt vinyl monomer and copolymer thereof | SLC7A1, ARSA, STS | MGLL 3058/4885FAAH 1069/4885L3MBTL1 4594/4885 |
| US-20230330245-A1 | ANTIBODY-EXATECAN CONJUGATES | ERBB3, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, IL23R | MGLL 4664/4885FAAH 4450/4885L3MBTL1 558/4885 |
| US-20050009982-A1 | Compound having silsesquioxane skeleton and its polymer | C1S, H1-4, H1-0 | MGLL 4700/4885FAAH 4471/4885L3MBTL1 1418/4885 |
| US-20250092171-A1 | HIGH-PURITY 4-(2-BROMOETHYL)BENZENESULFONIC ACID, HIGH-PURITY STYRENESULFONIC ACID COMPOUND DERIVED THEREFROM, AND POLYMER THEREOF, AND METHODS FOR PRODUCING SAME | BRPF1, WEE2, WEE1 | MGLL 4545/4885FAAH 4723/4885L3MBTL1 2465/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.